Overview
AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a cell-permeable synthetic nucleoside that acts as an AMP-activated protein kinase (AMPK) activator. It functions as an analog of adenosine monophosphate (AMP) that is capable of stimulating AMPK activity without altering concentrations of ATP or AMP. It is primarily used as a research compound to study the effects of AMPK activation on various physiological processes.
AICAR gained prominence due to studies demonstrating its ability to enhance endurance and glucose metabolism in animal models. This has led to interest in its potential therapeutic applications for metabolic disorders and as a performance-enhancing substance, although it is currently prohibited in sports.
While research has focused on its metabolic effects, AICAR's ability to modulate cellular energy balance has broader implications for various disease states, including cardiovascular disease and cancer. Further research is necessary to fully understand its therapeutic potential and safety profile in humans.
Mechanism of Action
AICAR's primary mechanism of action involves its conversion into ZMP (5-aminoimidazole-4-carboxamide ribonucleotide) inside cells. ZMP then directly activates AMPK, a crucial regulator of cellular energy homeostasis. AMPK activation triggers a cascade of downstream effects that enhance glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.
By activating AMPK, AICAR mimics the effects of exercise and energy deprivation at the cellular level. This leads to improved glucose metabolism, increased insulin sensitivity, and enhanced endurance capacity. The activation of AMPK also influences gene expression, promoting the production of proteins involved in energy metabolism and mitochondrial function.
Beyond its direct effects on AMPK, AICAR may also influence other signaling pathways involved in metabolism and inflammation. However, the precise mechanisms by which AICAR exerts its effects are still under investigation.
Key Benefits
- Potential to improve endurance
- May enhance glucose metabolism and insulin sensitivity
- Could have therapeutic applications for metabolic disorders
Research & Indications
Research on AICAR has primarily focused on its effects on metabolic function and endurance. Studies in animal models have shown that AICAR can improve glucose tolerance, increase fatty acid oxidation, and enhance exercise capacity. These findings have led to interest in its potential therapeutic applications for conditions such as type 2 diabetes and obesity.
AICAR has also been investigated for its potential role in cardiovascular disease. Studies have suggested that AICAR may protect against ischemia-reperfusion injury and improve cardiac function. Additionally, AICAR has shown promise in preclinical studies for cancer therapy, where it can inhibit cell growth and induce apoptosis in certain cancer cell lines.
While AICAR has demonstrated promising results in preclinical studies, further research is needed to evaluate its safety and efficacy in humans. Clinical trials are necessary to determine the optimal dosage and treatment duration, as well as to identify potential side effects and contraindications.
Dosing Protocols
Disclaimer: The following dosing information is for research purposes only and does not constitute medical advice. Consult with a qualified healthcare professional before using AICAR or any other peptide.
Typical research dosage:
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Enhanced Endurance | 50-150 mg | Daily or Every Other Day | SubQ or IM |
Supplies Needed
For an 8-week protocol:
- Peptide Vials: 4-8 vials of 50mg each (depending on dosage)
- Insulin Syringes (U-100): 50-70 syringes
- Bacteriostatic Water: 1-2 × 10mL bottles
- Alcohol Swabs: ~60-120 alcohol swabs
Side Effects & Safety
Reported side effects may include muscle discomfort, nausea, and elevated liver enzymes. As a research compound, the long-term safety profile of AICAR is not fully established. It is contraindicated for use in individuals with pre-existing liver or kidney conditions. It is important to monitor liver function during use.
Storage & Handling
AICAR should be stored in lyophilized form at -20°C. Once reconstituted with bacteriostatic water, it should be stored at 2-8°C and used within a few weeks.